Attached files

file filename
EX-4.5 - EX-4.5 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-4_5.htm
EX-4.4 - EX-4.4 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-4_4.htm
EXCEL - IDEA: XBRL DOCUMENT - EPIRUS Biopharmaceuticals, Inc.Financial_Report.xls
EX-32.1 - EX-32.1 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-32_1.htm
EX-10.6 - EX-10.6 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-10_6.htm
EX-23.1 - EX-23.1 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-23_1.htm
EX-31.2 - EX-31.2 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-31_2.htm
EX-31.1 - EX-31.1 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-31_1.htm
10-K - 10-K - EPIRUS Biopharmaceuticals, Inc.a2223738z10-k.htm
EX-10.4 - EX-10.4 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-10_4.htm
EX-10.5 - EX-10.5 - EPIRUS Biopharmaceuticals, Inc.a2223738zex-10_5.htm

Exhibit 21.1

 

Subsidiaries of EPIRUS Biopharmaceuticals, Inc.

 

Name of Wholly-Owned Subsidiary

 

Jurisdiction of Organization

EB Sub, Inc.

 

Delaware

Epirus Biopharmaceuticals Ltd.

 

United Kingdom

Epirus Switzerland GmbH

 

Switzerland

Epirus Brasil Tecnologia Ltda

 

Brazil

Zalicus Pharmaceuticals Ltd.

 

Canada